Product Description
Optimized solution to acute and chronic diseases
FIA8600 Quantitative Immunoassay Analyzer is a medical diagnostic instrument which can be used to measure a variety of biomarkers in human whole blood, serum, plasma or other specimens. Due to its portable and light weight design, the FIA8600 can be easily deployed at patient side, facilitating the clinical decisions with its rapid results. FIA8600 offers testing of cardiac markers, inflammation monitoring, diabetes, fertility, and renal function.
Test Items
Cardiac Marker |
cTnI, NT-proBNP, D-Dimer, CK-MB, NT-proBNP/cTnI, CK-MB/cTnI,
CK-MB/cTnI/Myo, hFABP, CK-MB/cTnI/hFABP |
Renal Function |
CysC, mAlb, NGAL, β2-MG |
Inflammation Monitoring |
hs-CRP+CRP, PCT |
Diabetes |
HbA1c |
Fertility |
HCG+β |
Company Profile
Getein Biotech Inc. (stock code: 603387), established in 2002, is a fully integrated in vitro diagnostic company that researches and develops, manufactures, markets and distributes a broad range of innovative diagnostic test kits in point-of-care, clinical chemistry, chemiluminescent assays, and molecular diagnostics. The company sits on a 10.5 square kilometers science park and is equipped with state-of-the-art R&D and production facilities. It also manufactures analytic medical devices and a variety of biological and non-biological raw materials for applications in diagnostics, pharmaceuticals, and academic research.